Page 22 - Q1 Results

FMCG shares in focus: HUL, Emami, Godrej Consumer gain up to 4%; here's why

At 11:15 AM; BSE FMCG index, the sole gainer among sectoral indices, was up 1 per cent, as compared to 0.5 per cent decline in the BSE Sensex.

Punjab National Bank falls 4% on Q1 results; should you buy, sell or hold?

PNB's share price was trading 2 per cent lower at ₹105.9 per share after the bank posted its June 2025 quarter results

IndiGo stock up 2% despite Q1 profit dip; what's fueling investor optimism?

During the quarter under review, InterGlobe Aviation reported a 20.25 per cent year-on-year (Y-o-Y) decline in consolidated net profit to ₹2,176.3 crore, down from ₹2,728.8 crore reported in Q1FY25

HUL Q1 profit rises 5.6% to ₹2,756 cr, expects FMCG demand to be stable

FMCG major says investments in its brands helped clock sales growth of 5%

HEG rallies 11% in weak market; what's driving graphite electrode stocks?

HEG and Graphite India shares rally up to 11% on Thursday; here's why analysts remain positive on HEG.

Q1 results today: HUL, Swiggy, Vedanta, Adani Enterprises on July 31

Q1 FY26 company results, July 31: PB Fintech, Maruti Suzuki, Ambuja Cements, JSW Energy, Dabur, Mackenzie, Coal India, Dr. Lal PathLabs, TVS Motor and will also release their April-June quarter earnin

PNB Q1 net profit plunges 48% to ₹1,675 crore on higher tax outgo

PNB's profit dips due to switch to new tax regime; operating metrics improve with better asset quality, strong retail credit growth and healthy capital adequacy

Hyundai Q1 FY26 profit down 8.1% amid weak demand, macro headwinds

Hatchback volumes shrink as SUV demand surges; Hyundai maintains margin despite cost pressures, bets on exports, rural reach and festive boost in second half

Procter & Gamble Hygiene Q1 net profit more than doubles to ₹192 crore

The company's revenue from operations was largely flat at ₹937 crore in the quarter ended June. Its advertising expenses were down 55.3 per cent in the at ₹69 crore

M&M Q1 PAT rises 24% to ₹4,083 crore on strong auto volume growth

Auto volumes rise 17 per cent, SUV market share improves 570 bps to 27.3 per cent, while farm and services also report healthy margins and profits in Q1FY26

Tata Steel Q1 PAT jumps 116% to ₹2,078 cr on cost cuts, better realisations

Total revenue on a consolidated basis in Q1FY26 was ₹53,178.12 crore, down 2.91 per cent Y-o-Y

IndiGo Q1 profit down 20.5% on airspace curbs, AI171 crash fallout

IndiGo's Q1 profit fell as geopolitical tensions, Pakistan airspace curbs, and AI171 crash drove cancellations and depressed yields despite higher passenger numbers

Strong Q1 results, guidance lift New India Assurance shares by 18%

New India Assurance shares soar as insurer posts 80 per cent rise in profit, guided for lower combined ratio despite underwriting hit from Air India crash

IIFL Finance Q1 net profit drops 19% on higher impairment provisions

Gold loan portfolio surges 85% while overall loan book rises 21% Y-o-Y in Q1FY26; net profit falls to Rs 274 crore due to doubling of impairment provisions

PowerGrid Q1FY26 results: Profit slips 2.5% to ₹3,630 cr on higher expenses

PowerGrid reported a rise in income to ₹11,444 crore; Board clears ₹55,000 crore fundraising and key JV, asset expansion plans

Mahindra EV biz posts ₹111 crore Q1 EBITDA, awaits PLI nod for XUV9e

Strong demand for electric SUVs boosts Mahindra's EV business to Rs 111 crore EBITDA in Q1FY26; company awaits PLI certificate and ramps up production gradually

JB Pharma Q1 profit up 14%, revenue up 9% on domestic segment gains

Domestic, CDMO and API businesses drive growth for JB Pharma in Q1FY26 as Razel crosses Rs 100 crore and ophthalmology portfolio sees 19 per cent expansion

JB Pharma Q1 results: Net profit up at 14% to ₹202 cr, revenue rises 9%

JB Chemicals & Pharmaceuticals Ltd on Wednesday reported a 14 per cent rise in net profit to Rs 202 crore in the June quarter. The company had posted a net profit of Rs 177 crore in the corresponding period of the previous fiscal year, JB Chemicals & Pharmaceuticals (JB Pharma) said in a regulatory filing. Revenue in the first quarter stood at Rs 1,094 crore as against Rs 1,004 crore in the same period a year ago, up 9 per cent, it added. "The domestic business recorded approximately 14 per cent value growth. This was driven by acute and chronic segments, including our ophthalmology portfolio. Our major brands & their franchises are also performing well," JB Pharma CEO and Wholetime Director, Nikhil Chopra said. He further said, "The CDMO (contract development and manufacturing organisation) business momentum is likely to sustain in coming quarters." The company said its domestic formulations business recorded revenue of Rs 678 crore as against Rs 595 crore in the first ...

Nexus Select Trust Q1 net income rises 12% to ₹460 cr on consumption boost

India's only retail REIT posts double-digit income growth in Q1FY26 on the back of strong leasing, higher consumption, and stable occupancy across malls

Tata Steel Q1 FY26 profit more than doubles to ₹2,078 cr; revenue down 3%

Tata Steel's revenue from operations declined by 3 per cent year-on-year (Y-oY) to ₹52,744 crore in Q1 FY26, down from ₹54,412 crore in Q1 FY25